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OBJECTIVE—To investigate the association between ﬁrst-trimester maternal serum levels of
25-hydroxyvitamin D (25-OH-D) as measured by liquid chromatography-tandem mass spec-
trometry and development of gestational diabetes mellitus (GDM).
RESEARCH DESIGN AND METHODS—We conducted a case-control study involving
248 women in the ﬁrst-trimester of pregnancy, 90 of whom developed GDM and 158 remained
normoglycemic.
RESULTS—Although booking 25-OH-D levels correlated negatively with 2-h glucose post-
oral glucose tolerance test and positively with HDL cholesterol, aswellas with ethnicity,obesity,
andsmoking(allP,0.05),therewerenostatisticallysigniﬁcantdifferencesinbaselinematernal
mean 25-OH-D levels between those who subsequently developed GDM, 18.9 ng/mL (SD 10.7)
and those who remained normoglycemic, 19.0 ng/mL (10.7) (P = 0.874), even after adjustment
for possible confounders including sampling month (P =0 . 7 8 4 ) .
CONCLUSIONS—Ourlargeandwell-phenotypedprospectivestudydidnotﬁndevidenceofan
associationbetweenﬁrst-trimestermaternallevelsof25-OH-DandsubsequentdevelopmentofGDM.
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G
estational diabetes mellitus (GDM)
markedly increases risk of type 2
diabetes in later life (1). Lower
25-hydroxyvitamin D (25-OH-D) con-
centrations have been inversely associ-
ated with maternal glycemia (2), insulin
resistance (3), and increased risk of GDM
(4). However, further studies are needed
to examine the relevant associations,
givenitstopicalityandpotentialforclinical
impact. This is even more so the case
given that the nonpregnant arena results
of observational studies and trials of
25-OH-D in diabetes conﬂict, with eight
trials showing no effect of 25-OH-D
supplementation on glycemia or incident
diabetes (5).
Usingawell-phenotypedpopulationof
ﬁrst-trimesterwomen(6),werecentlydem-
onstrated that GDM can be predicted from
simple clinical and laboratory parameters.
We subsequently measured 25-OH-D on
available samples and sought to examine
the relationship of ﬁrst-trimester 25-OH-D
levels with development of GDM.
RESEARCH DESIGN AND
METHODS—We used ﬁrst-trimester
blood samples from 90 women who
subsequently developed GDM and 158
control subjects. GDM was deﬁned by at
least one abnormal plasma glucose value
following the oral glucose tolerance test
(OGTT) with normal values of ,6a n d
,7.8 mmol/Lfor the fasting and 2-h post-
prandial samples, respectively (World
Health Organization criteria). Maternal
ﬁrst-trimester serum 25-OH-D3 and D2
were measured using an automated solid-
phase extraction procedure with liquid
chromatography-tandem mass spectrome-
try(LC-MS/MS)(7).Thelowerlimitofsen-
sitivity was 4 nmol/L for 25-OH-D3 and
7.5 nmol/L for 25-OH-D2. Within- and
between-assay precision was below 10%.
Results are reported as total 25-OH-D
(25-OH-D2 +2 5 - O H - D 3). A comprehen-
sive description of prospective recruitment
and exclusion criteria and the lipid and
metabolic parameters measured have pre-
viously been reported (6). Variables are
summarized as mean (SD), median (quar-
tiles), or n (%) per category; groups have
been compared using t tests, Wilcoxon
tests, or Fisher exact tests as appropriate
and using logistic regression analyses ad-
justing for different variables. Linear regres-
sion analysis has been used to assess the
association between log-transformed 25-
OH-D and demographic and medical his-
toryvariables.Associationsofglucose,lipid,
and blood pressure measures with log-
transformed 25-OH-D have also been
assessed with linear regression, with and
without adjustment for potentially con-
founding demographic and medical history
variables. All analyses have been carried out
in R (version 2.11.0) (http://www.R-project.
org). P values are not corrected for multiple
testingandshouldbeconsidereddescriptive.
RESULTS—Women who developed
GDM had a greater BMI, a prior history
of GDM, and a family history of type 2
diabetes (Table 1). They also had higher
systolic blood pressure, but therewere no
relevant differences in parity, smoking
history, or method of conception. How-
ever,booking25-OH-Dlevelsdidnotdif-
fer signiﬁcantly between case and control
subjects in univariate analyses or after
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BRIEF REPORTadjustment for confounders, and inclusion
of25-OH-Ddidnotenhanceﬁrst-trimester
prediction of GDM (data not shown).
Restriction of analyses to women with
no history of GDM did not alter conclu-
sions, and separate examination by ethnic
or BMI groups did not either. There were
also no relevant differences in proportions
ofwomenwhohaddeﬁcientorinsufﬁcient
25-OH-D levels (Table 1).
In univariate association analyses, 25-
OH-Dlevelswerepositivelyassociatedwith
maternal age (2.7% per year; P = 0.001)
and negatively with BMI at 12 weeks’ ges-
tation (21.8% per kg/m
2; P = 0.004). 25-
OH-D was lower in smokers (P = 0.012),
black and Asian women (P , 0.001 and
P = 0.003, respectively), and women with a
family history of diabetes (P = 0.017). 25-
OH-D was positively associated with HDL
cholesterol (P = 0.004) and negatively asso-
ciated with fasting glucose (P = 0.009), 2-h
glucose (P = 0.002), and HbA1c (P = 0.002)
at 28 weeks’ gestation (Supplementary
Table 1). After adjustment for booking
month, age, BMI, smoking, ethnicity,
and family history of diabetes, 25-OH-D
levels remained negatively correlated
only with 2-h glucose and positively as-
sociated with HDL cholesterol in the
Table 1—Characteristics of mothers with GDM vs. control mothers
Missing values Control mothers Mothers with GDM Punivariate Padjusted1 Padjusted2
n 158 90
Maternal age (years) 0/0 33.1 6 4.7 34.2 6 4.9 0.104* 0.415 0.415
Maternal BMI at 12 weeks (kg/m
2)0 / 0 2 5 . 2 6 4.0 30.0 6 7.9 ,0.001† ,0.001 ,0.001
Ethnicity 0/0 0.735‡ 0.901 0.901
White 108 (68.4%) 58 (64.4%)
Black 31 (19.6%) 23 (25.6%)
Asian 12 (7.6%) 6 (6.7%)
Other 7 (4.4%) 3 (3.3%)
Parity 0/0 1.000‡— —
Nulliparous 67 (42.4%) 38 (42.2%)
Parous 91 (57.6%) 52 (57.8%)
Previous GDM 0/0 ,0.001‡— —
No 158 (100%) 69 (76.6%)
Yes 0 (0.0%) 21 (23.3%)
Family history of diabetes 0/0 ,0.001‡ 0.037 0.037
No 141 (89.2%) 55 (61.1%)
Yes 17 (10.8%) 35 (38.9%)
Smoker 0/0 0.795‡ 0.884 0.884
No 148 (93.7%) 83 (92.2%)
Yes 10 (6.3%) 7 (7.8%)
Gestational age at booking (days) 0/0 87.5 6 3.0 87.4 6 3.6 0.916* 0.886 0.886
Systolic blood pressure (mmHg) 37/20 112.5 6 15.8 118.5 6 11.6 0.003* 0.039 0.039
Diastolic blood pressure (mmHg) 37/20 70.2 6 8.5 71.7 6 7.2 0.218* 0.167 0.167
Sex 1/0 0.356‡ 0.730 0.730
Female 77 (49.0%) 50 (55.6%)
Male 80 (51.0%) 40 (44.4%)
Birth weight (g) 1/0 3,403.1 6 571.4 3,283.6 6 481.9 0.081* 0.388 0.388
Gestation at OGTT (weeks) 0 28.0 6 4.6
OGTT
Fasting/2-h glucose (mmol/L) 0/3 5.3 6 1.8/9.1 6 1.8
HbA1c (%) 11 5.8 6 0.9
Total cholesterol (mmol/L) 0/0 4.62 6 0.76 4.86 6 0.90 0.033* 0.780 0.780
HDL cholesterol (mmol/L)^ 0/0 1.74 (0.35) 1.58 (0.38) 0.001* 0.009 0.009
Triglyceride (mmol/L)^ 0/0 1.20 (0.95–1.56) 1.38 (1.08–2.01) 0.002* 0.423 0.423
25-OH-D (ng/mL) 0/0 19.0 6 10.7 18.9 6 10.7 0.874† 0.784 0.784
25-OH-D (nmol/L) 0/0 47.6 6 26.7 47.2 6 26.7 0.863† 0.782 0.782
Deﬁcient 25-OH-D (,25 nmol/L)
No 0/0 122 (77.2%) 72 (80.0%) 0.635‡ 0.864 0.864
Yes 36 (22.8%) 18 (20.0%)
Insufﬁcient 25-OH-D (,50 nmol/L) 0/0 0.502‡ 0.742 0.742
No 68 (43.0%) 34 (37.8%)
Yes 90 (57.0%) 56 (62.2%)
Months of sampling 0/0 6.4 6 3.3 6.8 6 3.2 0.426* 0.314 0.314
Data are means 6 SD, median (interquartile range), or n (%). Padjusted1, logistic regression adjusted for maternal age, BMI, gestational age at sampling, smoking,
ethnicity, parity, conception status, and previous GDM; 25-OH-D levels additionally adjusted for month of sampling. Padjusted2, women without previous GDM
(nulliparous or previous pregnancies without GDM) logistic regression adjusted for maternal age, BMI, gestational age at sampling, smoking, ethnicity, parity, and
conception status; 25-OH-D levels additionally adjusted for month of sampling. *t test. †Wilcoxon test. ‡Fisher exact test. ^Log-transformed for regression analysis.
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First-trimester circulating 25-OH-D and GDMentire group and women without prior
GDM (Supplementary Table 2).
CONCLUSIONS—Using a very well-
phenotyped cohort, we found that ﬁrst-
trimester maternal 25-OH-D levels,
despite being associated with 2-h glu-
coselevels(independentlyofage,obesity,
smoking, and ethnicity, etc.), are not sig-
niﬁcantly associated with the development
of GDM. A single study has demonstrated
anindependentassociationof25-OH-Dat
16 weeks’ gestation with GDM as deﬁned
by American Diabetes Association criteria
(4); however, 25-OH-D deﬁciency was
much less prevalent and 25-OH-D levels
weredeterminedbyimmunoassay,ameth-
odology subsequently dropped by the
Centers for Disease Control in favor of
LC-MS/MS as a result of the poor speci-
ﬁcity of immunoassays compared with
chromatographic methods (8). Whether
these differences underlie the differences
in ﬁndings is unclear. It is also unclear
why 25-OH-D levels continue to corre-
late with 2-h OGTT levels despite lack
of baseline difference in 25-OH-D levels
in women who do and do not develop
GDM.Thepotentialforresidualconfound-
ingmustbeborneinmind.However,given
that our study was larger (90 incident
cases vs. 57 in that of Zhang et al. [4]),
used more robust LC-MS/MS, and was
conducted about 4 weeks earlier in ges-
tation, lack of difference in ﬁrst-trimester
25-OH-D is of relevance and suggests a
need to caution against recommending
greater 25-OH-D supplementation in
pregnancy, at least as a mechanism to
lessen risk for GDM.
Although there was no evidence of a
relationof25-OH-DwithGDM,theprev-
alence of 25-OH-D deﬁciency (~20%)
within our inner-city multiethnic popula-
tionwasnotable.Intheearly1990s,90%of
white pregnant mothers in the Avon Lon-
gitudinal Study of Parents And Children
(ALSPAC) study had 25-OH-D concentra-
tions ,50 nmol/L during winter and
spring; 28% were seriously deﬁcient
(,25nmol/L),andvirtuallynoonereached
75 nmol/L (considered optimal) (9), with
similarestimatesfoundinothercomparable
pregnancy cohorts (10,11). Since then,
despite signiﬁcant public health efforts to
ensure that all pregnant women achieve
25-OH-D intakes of 10 mg/day (400
IU/day) (12), there appears to have been
little positive impact on hypovitaminosis
Dprevalence.Thatnoted,25-OH-Dlevels
do not appear to have worsened consider-
ably, at least as judged by comparing the
present data with the aforementioned
ALSPAC ﬁndings. This observation sug-
gests that factors other than 25-OH-D
deﬁciency(i.e.,risingobesityratesinpreg-
nancy in particular) likely explain rising
GDM rates. To resolve uncertainties about
vitamin D and pregnancy outcomes, there
is a need for well-conducted and ade-
quately powered studies of vitamin D in-
take in pregnancy. Until such time, the
current study goes against a major role
for vitamin D deﬁciency in the pathogen-
esis of GDM.
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